Septerna Shares Jump 42% After IPO Shows Biotech Still Hot [Yahoo! Finance]
Upstream Bio, Inc. (UPB)
Company Research
Source: Yahoo! Finance
Most Read from Bloomberg Robotaxis Are No Friend of Public Transportation Booming Cambridge Exposes England's Widening Wealth Gap Oman Sees an Urban Future Distinct From Dubai and Abu Dhabi Argentina Drug Trafficking Hotspot Sees Murders Plunge Climate Change Is Killing Buildings in Slow Motion The South San Francisco-based firm's shares traded at $25.50 each at 12:15 p.m. on Friday in New York, above the IPO price of $18 apiece. The company had increased the size of the stock sale twice and sold 16 million shares on Thursday at a price above an initially marketed range. The trading gives Septerna a market value of more than $1 billion, based on the outstanding shares listed in its filings. The company is focused on developing oral small molecule drugs with an initial focus on endocrinology, immunology and inflammation, and metabolic diseases, according to its website. The strong pricing and trading follows a spate of IPOs and follow-on offerings over the past two m
Show less
Read more
Impact Snapshot
Event Time:
UPB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UPB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UPB alerts
High impacting Upstream Bio, Inc. news events
Weekly update
A roundup of the hottest topics
UPB
News
- Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business HighlightsGlobeNewswire
- Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $75.00 price target on the stock.MarketBeat
- Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock.MarketBeat
- Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.MarketBeat
UPB
Sec Filings
- 11/8/24 - Form SEC
- 11/8/24 - Form SEC
- 11/7/24 - Form SC
- UPB's page on the SEC website